½ÃÀ庸°í¼­
»óǰÄÚµå
1346847

¼¼°èÀÇ ´ÏÄÚÆ¾ ²­ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2023-2030³â)

Global Nicotine Gum Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 140 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´ÏÄÚÆ¾ ²­(Nicotine Gum) ½ÃÀå ¼ö¿ä´Â Á¶»ç ±â°£ÀÎ 2023-2030³â CAGR 6.5%·Î ÃßÀÌÇÏ¸ç ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2022³âÀÇ 23¾ï ´Þ·¯¿¡¼­ 2030³â¿¡´Â 38¾ï 1,000¸¸ ´Þ·¯ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

´ÏÄÚÆ¾ ²­Àº ´ã¹è¿¡¼­ ¹ß°ßµÇ´Â È­ÇÕ¹°ÀÎ ´ÏÄÚÆ¾À» ÇÔÀ¯ÇÑ ¾Ã´Â ²­ÀÔ´Ï´Ù. ´ã¹è ¿¬±â¿Í °ü·ÃµÈ À¯ÇØÇÑ µ¶¼Ò ¹× ¹ß¾Ï ¹°Áú ¾øÀÌ ´ÏÄÚÆ¾ÀÇ ¾çÀ» Á¶ÀýÇÏ¿© ±Ý¿¬À» µ½µµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ÀÌ ²­Àº ´ÏÄÚÆ¾ ÀÇÁ¸µµ¸¦ Á¡ÁøÀûÀ¸·Î ÁÙÀÌ°í ±Ý´Ü Áõ»óÀ» ±Øº¹ÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ±Ý¿¬ º¸Á¶Á¦·Î ÀÚÁÖ »ç¿ëµË´Ï´Ù.

½ÃÀå ¿ªÇÐ :

´ÏÄÚÆ¾ ²­ ½ÃÀåÀº Èí¿¬°ú °ü·ÃµÈ °Ç°­ ¹®Á¦ Áõ°¡, ±Ý¿¬ ³ë·Â, ±ÔÁ¦ Áö¿ø, ´ÏÄÚÆ¾ Áßµ¶À» ±Øº¹ÇÏ·Á´Â ¿å±¸ µîÀÇ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ´ÏÄÚÆ¾ ²­Àº ´ÏÄÚÆ¾ÀÇ Áßµ¶¼ºÀ» ÇØ°áÇÏ°í ¼º°øÀûÀÎ ±Ý¿¬¿¡ ÇʼöÀûÀÎ Çൿ º¯È­¸¦ µ½½À´Ï´Ù. À¯Çؼº °¨¼Ò Ãø¸éÀº »ç¿ëÀÚ°¡ ´ã¹è °ü·Ã À¯ÇØ µ¶¼Ò¿¡ ³ëÃâµÇÁö ¾Ê°í ´ÏÄÚÆ¾ ¿å±¸¸¦ ÃæÁ·ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â Áß¿äÇÑ ¿ä¼ÒÀÔ´Ï´Ù. ±ÔÁ¦ Á¶Ä¡, Á¢±Ù¼º, ´ëÁß ÀÎ½Ä Ä·ÆäÀÎÀº ´ÏÄÚÆ¾ ²­ÀÇ ¼ö¿ä Áõ°¡¿¡ ´õ¿í ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á Àü¹®°¡ÀÇ ±Ç°í, Èí¿¬¿¡ ´ëÇÑ »çȸÀû ÀνÄÀÇ º¯È­, °³ÀÎ ¸ÂÃãÇü Á¢±Ù ¹æ½Äµµ ´ÏÄÚÆ¾ ²­ÀÇ ¸Å·ÂÀ» ´õÇÕ´Ï´Ù. »ç¶÷µéÀÌ ±Ý¿¬À» À§ÇÑ ´õ °Ç°­ÇÑ ´ë¾È°ú °³ÀÎ ¸ÂÃãÇü ¼Ö·ç¼ÇÀ» ãÀ¸¸é¼­ ´ÏÄÚÆ¾ ²­ ½ÃÀåÀº Á¾ÇÕÀûÀÎ ±Ý¿¬ Àü·«ÀÇ Çʼö ¿ä¼Ò·Î¼­ Áö¼ÓÀûÀ¸·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Âµµ ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´ë»óÀ¸·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â »ê¾÷ÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀï ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â ´ÏÄÚÆ¾ ²­ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ´ÏÄÚÆ¾ ²­ »ê¾÷ ¼ºÀå ¹× µ¿ÇâÀºÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼® :

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾Æ ÅÂÆò¾ç, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ´ÏÄÚÆ¾ ²­ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ÀÌ º¸°í¼­´Â ¸ðµç À¯¸íÇÑ Áö¿ª¿¡ °ÉÄ£ °³º° ¿ëµµ ºÎ¹®¿¡ ´ëÇÑ ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì ´ç»ç¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¿¬±¸Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ½ÃÀå ÇöȲ

Á¦3Àå ´ÏÄÚÆ¾ ²­ »ê¾÷ ºÐ¼®

  • ¼Ò°³ : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø ¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦ ¿äÀÎ
  • ±âȸ
  • »ê¾÷ µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸ñ·Ï
    • ¿øÀç·á Á¦Á¶»ç ¸ñ·Ï
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ±¸¸ÅÀÚ ¸ñ·Ï
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ´ÏÄÚÆ¾ ²­ ½ÃÀå ºÐ¼® : À¯Çüº°

  • À¯Çüº° °³¿ä
  • ½ÇÀû ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • À¯Çüº° ºÐ¼®
  • 2mg
  • 4mg

Á¦6Àå ´ÏÄÚÆ¾ ²­ ½ÃÀå ºÐ¼® : À¯Åë ä³Îº°

  • À¯Åë ä³Îº° °³¿ä
  • ½ÇÀû ¹× ¿¹Ãø µ¥ÀÌÅÍ
  • À¯Åë ä³Îº° ºÐ¼®
  • ½´ÆÛ¸¶ÄÏ/ÇÏÀÌÆÛ¸¶ÄÏ
  • ÆíÀÇÁ¡
  • ¾à±¹
  • ¿Â¶óÀÎ

Á¦7Àå ´ÏÄÚÆ¾ ²­ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾Æ ÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾Æ ÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾Æ ÅÂÆò¾ç
  • ³²¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • ³²¹Ì : ºÎ¹®º°
    • ³²¹Ì : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû ¹× ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä« °øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå ´ÏÄÚÆ¾ ²­ ±â¾÷ °æÀï ±¸µµ

  • ´ÏÄÚÆ¾ ²­ ½ÃÀå °æÀï
  • Á¦ÈÞ¡¤Çù·Â¡¤ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦9Àå ±â¾÷ °³¿ä

  • »óÀ§ ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Johnson&Johnson
  • Novartis AG
  • ITC Limited
  • Cipla Health Limited
  • Perrigo Company Plc.
  • Teva Canada
  • Philip Morris
  • British American Tobacco PLC
LYJ 23.10.11

The global demand for Nicotine Gum Market is presumed to reach the market size of nearly USD 3.81 BN by 2030 from USD 2.3 BN in 2022 with a CAGR of 6.5% under the study period 2023 - 2030.

Nicotine gum is a chewing gum containing nicotine, a chemical compound found in tobacco. It is designed to help individuals quit smoking by controlling doses of nicotine without the harmful toxins and carcinogens associated with tobacco smoke. This gum is often used as a smoking cessation aid to help people gradually reduce their nicotine dependence and overcome withdrawal symptoms.

MARKET DYNAMICS:

The Nicotine gum market is driven by factors such as increasing health concerns related to smoking, efforts to quit smoking, regulatory support, and a desire to overcome nicotine addiction. It addresses the addictive nature of nicotine and aids in behavioural changes that are crucial for successful quitting. The harm reduction aspect is significant, allowing users to satisfy nicotine cravings without exposing themselves to harmful tobacco-related toxins. Regulatory measures, accessibility, and public awareness campaigns further contribute to the demand for nicotine gum. Healthcare professionals' recommendations, changing social perceptions about smoking, and personalized approaches add to its appeal. As people seek healthier alternatives and personalized solutions for quitting smoking, the Nicotine gum market is poised for continued growth as an essential component of comprehensive smoking cessation strategies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of nicotine gum. The growth and trends of nicotine gum industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the nicotine gum market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • 2Mg
  • 4Mg

By Distribution Channel

  • Supermarkets/Hypermarkets
  • Convenience Stores
  • Pharmacies
  • Online

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Nicotine Gum market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Nicotine Gum market include Johnson & Johnson, Novartis AG, ITC Limited, Cipla Health Limited, Perrigo Company Plc., Teva Canada, Philip Morris, British American Tobacco PLC. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . NICOTINE GUM - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Distribution Channel
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL NICOTINE GUM MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 2mg Historic and Forecast Sales by Regions
  • 5.5 4mg Historic and Forecast Sales by Regions

6 . GLOBAL NICOTINE GUM MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 6.1 Overview by Distribution Channel
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Distribution Channel
  • 6.4 Supermarkets/Hypermarkets Historic and Forecast Sales by Regions
  • 6.5 Convenience Stores Historic and Forecast Sales by Regions
  • 6.6 Pharmacies Historic and Forecast Sales by Regions
  • 6.7 Online Historic and Forecast Sales by Regions

7 . GLOBAL NICOTINE GUM MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE NICOTINE GUM COMPANIES

  • 8.1. Nicotine Gum Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF NICOTINE GUM INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Johnson & Johnson
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Novartis AG
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. ITC Limited
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Cipla Health Limited
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Perrigo Company Plc.
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Teva Canada
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Philip Morris
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. British American Tobacco PLC
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦